Murillo de Souza Tuckumantel

Murillo de Souza Tuckumantel

Auto-generated profile, based on publicly available information

Murillo de Souza Tuckumantel

São José do Rio Preto School of Medicine (FAMERP), São José do Rio Preto, SP, Brazil

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2022 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
MMMarina Gobbe Moschetta-Pinheiro
Marina Gobbe Moschetta-Pinheiro
JCJucimara Colombo
Jucimara Colombo
MTMurillo de Souza Tuckumantel
Murillo de Souza Tuckumantel
GRGabriela Karam Rebolho
Gabriela Karam Rebolho
Debora Aparecida Pires Campos ZuccariDebora Aparecida Pires Campos Zuccari
Debora Aparecida Pires Campos Zuccari
Background: The most aggressive breast cancer is the triple negative histological type, and the gold standard for its treatment is platinum salts, such as carboplatin. Due to high recurrence, there is a need to test new drugs, such as PARP inhibitors (PARPi), that induce lethality in cells with DNA damage. Olaparib is a PARPi, already used in some tumors but not tested in canine species. Thus, the aim of this study was to demonstrate the efficacy of olaparib in inhibiting DNA repair and control disease progression by decreasing the migration capacity of mammary tumor cells. Methods: The cell lines CF41.Mg and MDA-MB-468 were cultured and MTT was performed to define the best dose of carboplatin. Next, the cells were treated with 10 μM carboplatin, olaparib, and with a combination of both for 24 hours. PARP-1 protein and gene expression were evaluated by immunofluorescence, western blotting, and qRT-PCR, respectively. The analysis of cell migration was performed in transwell chambers. Results: For CF41.Mg and MDA-MB-468 cell lines, there was a decrease in PARP-1 protein and gene expression after treatment with carboplatin, olaparib, and both in combination compared to the group without treatment (control) (p<0.05). Moreover, in both lines, a reduction in invasion rate was observed after treatment with carboplatin, olaparib and when combined, compared to the control group (p<0.05). Conclusion: Our data suggest that carboplatin and olaparib were able to block DNA repair and control the cancer invasion, especially when used in combination. The results with olaparib in the canine line are unpublished. The olaparib should be a possible agent against human breast cancer and canine mammary tumors.

1 January 2022 in Revista do Instituto de Medicina Tropical de São Paulo
Verified
Journal Article
Open access
MSMaria Lúcia Machado Salomão
Maria Lúcia Machado Salomão
Mauricio MachadoMauricio Machado
Mauricio Machado
EFEder Gatti Fernandes
Eder Gatti Fernandes
FQFlávia Queiroz
Flávia Queiroz
LMLina de Moura Mendes
Lina de Moura Mendes
MCMarcia Wakai Catelan
Marcia Wakai Catelan
This study aimed to evaluate the COVID-19 hospitalizations in a tertiary hospital by age group and month, considering the introduction and the advance of the vaccination against the disease. The laboratory-confirmed COVID-19-associated hospitalizations among people aged 20 years or older, that occurred between March 2020 and June 2021, were distributed by month of symptom onset and age group. The proportion of hospitalizations by age group was calculated for the year 2021. The proportions were compared using the chi-square test for trends. The marks of vaccination advances among different age groups were taken from the official website LocalizaSUS. In 2020, hospitalizations among people aged 60–80 years old were the most frequent (39.1%). From January–June 2021, when the vaccination commenced, while hospitalizations of patients aged 20 to < 40 and 40 to 60 years old showed an increasing trend, the older age groups and those with vaccination recommendations (from 60 to < 80 and from 80 or over) showed a downward trend. As of June 2021, with widespread vaccination, a drop in hospitalizations was observed in > 60 years old. At 20 to <40 and 40 to < 60, an increase in hospitalizations was observed. It demonstrates the important role of vaccination in combating the COVID-19 pandemic.

1 March 2023 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
JRJoão Henrique Godoy Rodrigues
João Henrique Godoy Rodrigues
MTMurillo de Souza Tuckumantel
Murillo de Souza Tuckumantel
LSLuís Cesar Fava Spessoto
Luís Cesar Fava Spessoto
Fernando FacioFernando Facio
Fernando Facio

1 October 2024 in AME Case Reports
Verified
Journal Article
Open access
PDF file
MTMurillo de Souza Tuckumantel
Murillo de Souza Tuckumantel
IAIsabela Claudino Altomari
Isabela Claudino Altomari
CGCamila Manzati Galvani
Camila Manzati Galvani
ATAna Luísa Alcaide Thomaz
Ana Luísa Alcaide Thomaz
LMLucas Carvalho Carrijo Madurro
Lucas Carvalho Carrijo Madurro
SNSebastião Schmidt Neto
Sebastião Schmidt Neto
Background: Multiple endocrine neoplasia type 2B (MEN2B) is a rare autosomal dominant syndrome characterized by medullary carcinoma of the early thyroid, pheochromocytoma, and non-endocrine manifestations, such as marfanoid habits and other skeletal abnormalities as well as mucosal neuromas and ganglioneuromatosis of the gastrointestinal tract. Case Description: A 10-year-old male began follow-up at our service at 3 years of age through pediatric gastroenterology due to intestinal constipation. The mother also reported that the child had painless lesions on the tip of the tongue since birth with progressive worsening. The patient simultaneously began follow-up with pediatric endocrinology due to low gains in weight and height, between which only isolated low weight was found, and the onset of follow-up with the pediatric neurology team due to longstanding headache combined with vomiting, photophobia, and phonophobia as well as a specific reading and writing disorder. The patient was sent to clinical genetics. The child’s karyotype was 46, XY (normal). Through a physical examination, the pediatric neurology team identified joint hypermobility, important muscle hypotrophy, gingival hypertrophy, and lipodystrophy. The patient was sent to neurogenetics, initiating a set of general laboratory exams for the investigation of the lipodystrophy and a panel of exams for lipodystrophy, neuropathy, and muscle hypotrophy as well as electroneuromyography. MEN2B due to genetic mutation was confirmed and the patient was sent to the pediatric endocrinology clinic for follow-up. Currently 10 years of age and again with the pediatric endocrinology team for the diagnosis of MEN2B, the investigation of pheochromocytoma and medullary thyroid cancer was initiated. Conclusions: An additional mutation occurs in most cases of MEN2B. The diagnosis is only established when the child or, in most cases, adolescent presents with medullary thyroid cancer in an advanced and even metastatic stage. However, non-endocrine manifestations, can lead to an early diagnosis and timely intervention. The diagnosis of MEN2B is made with the confirmation of the autosomal dominant genetic mutation or a mutation of the RET gene. In the absence of these mutations, the majority of clinical manifestations should be present.

1 January 2025 in AME Case Reports
Verified
Journal Article
Open access
PDF file
GBGabriel de Azambuja Beigin
Gabriel de Azambuja Beigin
JRJoao Henrique Godoy Rodrigues
Joao Henrique Godoy Rodrigues
MTMurillo de Souza Tuckumantel
Murillo de Souza Tuckumantel
WCWaldomiro Camargo
Waldomiro Camargo
AOAna Beatriz Souza de Oliveira
Ana Beatriz Souza de Oliveira
CCCarlos Abib Cury
Carlos Abib Cury
Background: Urolithiasis (kidney stone) is a common condition that often leads patients to urgent or emergency care services. Urinary calculi are generally found in the kidneys, ureters, or bladder. Urethral calculi are uncommon and can result from the migration of a calculus in the upper urinary tract or vesicle or may be primary of the urethra. Prostatic calculi are a rarity. Case Description: A 34-year-old male was admitted to the emergency service of a university hospital reporting dysuria and pain in the hypogastrium with a 4-day history. The patient reported that the pain sometimes irradiated to the left flank, accompanied by micturition effort, a weak urinary stream, pollakiuria, and urine output with a crystal appearance. The clinical history revealed urinary difficulty since 10 years of age. The patient was submitted to radiological investigation. Pelvic computed tomography revealed a voluminous calculus with slightly lobulated contours in the intravesical topography in the interior of the prostatic urethra. Urethrocystography revealed a prostatic calculus and the tapered passage of contrast through the prostatic urethra. After the diagnosis, the rectal examination confirmed the presence of a hardened calculous mass in the prostatic topography. Considering the complementary evaluation of the patient, perineal prostatotomy was planned. Prostatotomy was performed longitudinally in the prostatic capsule for the removal of the calculus after its release by dissection. Conclusions: In cases of patients with urinary retention treated at an emergency service, the following diagnostic hypotheses should be investigated: benign hyperplasia of the prostate, urethral stenosis, prostatic urethral calculus, and prostatic calculus. In prostatic calculus, regarding access for definitive surgery, in this case, the perineal route proved to be the best therapeutic option.